PD29-09 APPLICABILITY OF BRIGANTI NOMOGRAM: AN ABSOLUTE REQUIREMENT BEFORE LYMPH NODE DISSECTION IN INTERMEDIATE-RISK PROSTATE CANCER? ASSESSMENT OF THE EXTERNAL APPLICABILITY. | Zendy

AI Assistant Blog Pricing

PD29-09 APPLICABILITY OF BRIGANTI NOMOGRAM: AN ABSOLUTE REQUIREMENT BEFORE LYMPH NODE DISSECTION IN INTERMEDIATE-RISK PROSTATE CANCER? ASSESSMENT OF THE EXTERNAL APPLICABILITY.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.